SSR4 Promote Gastric Cancer Progression by Regulating Mitochondrial Oxidative Phosphorylation via NDUFB11 and ATP6AP1
Molecular Carcinogenesis · 2025-12 · 64 (12) · 2026-2036
DOI: 10.1002/mc.70047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Carcinogenesis, online erschienen am 25.09.2025. Verfasst von Aoshuang Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The Third People's Hospital of Chengdu, Affiliated Hospital of Southwest Jiaotong University, Chengdu, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Oxidative Phosphorylation, Mitochondria, Electron Transport Complex I. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: This study was funded by the foundation of Chengdu Municipal Science and Technology Bureau (2024-YF05-00853-SN), The Third People's Hospital of Chengdu Scienti….
Abstract (Originalsprache)
Gastric cancer (GC) is one of the most common cancers worldwide. Cancer cell metastasis is a major factor leading to poor prognosis. Previous proteomic data suggested that SSR4 might be closely associated with the occurrence and development of GC. However, the role and molecular mechanism of SSR4 in GC is not yet clear. The present study found that the expression level of SSR4 was increased in GC tissue and serum from GC patients. In addition, SSR4 could promote the malignant biological behavior of GC cells in vitro and in vivo. The mechanism may be that SSR4 regulates the expression of NDUFB11 and ATP6AP1, and then enhanced the function of mitochondrial respiratory chain complex I (CI) and mitochondrial respiratory chain complex V (CV), which promoted the mitochondrial oxidative phosphorylation and thus promoted GC progression. These findings expand the understanding of the role of SSR4 and provide a new target for the treatment of GC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, The Third People's Hospital of Chengdu, Affiliated Hospital of Southwest Jiaotong University, Chengdu, China.
- College of Medicine, Southwest Jiaotong University, Chengdu, China.
- Department of Ultrasound, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
- School of Pharmacy, North Sichuan Medical College, Nanchong, China.
- Department of Pediatrics, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
- Medical Research Center, The Third People's Hospital of Chengdu, Affiliated Hospital of Southwest Jiaotong University, Chengdu, China.
Förderung
- This study was funded by the foundation of Chengdu Municipal Science and Technology Bureau (2024-YF05-00853-SN), The Third People's Hospital of Chengdu Scienti…
Zitieren
APA
Li, A., Liao, B., Wu, K., Fan, R., Zhu, B., Sun, X., & Liu, L. (2025). SSR4 Promote Gastric Cancer Progression by Regulating Mitochondrial Oxidative Phosphorylation via NDUFB11 and ATP6AP1. Molecular Carcinogenesis, 64(12), 2026-2036. https://doi.org/10.1002/mc.70047
Vancouver
Li A, Liao B, Wu K, Fan R, Zhu B, Sun X, et al. SSR4 Promote Gastric Cancer Progression by Regulating Mitochondrial Oxidative Phosphorylation via NDUFB11 and ATP6AP1. Molecular Carcinogenesis. 2025;64(12):2026-2036. doi:10.1002/mc.70047
BibTeX
@article{Li2025,
author = {Li, Aoshuang and Liao, Baixue and Wu, Kaiwen and Fan, Ruiling and Zhu, Binjun and Sun, Xiaobin and Liu, Lei},
title = {SSR4 Promote Gastric Cancer Progression by Regulating Mitochondrial Oxidative Phosphorylation via NDUFB11 and ATP6AP1},
journal = {Molecular Carcinogenesis},
year = {2025},
volume = {64},
number = {12},
pages = {2026--2036},
doi = {10.1002/mc.70047}
}
EUVIMED